Senior insider sale
Chief Medical Officer at DYNE THERAPEUTICS, INC. — senior position signals high conviction
$149.0K
6.22K shares
What this filing means
KERR DOUGLAS plans to sell 6.22K shares of DYNE THERAPEUTICS, INC. valued at approximately $149.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2026ACC: 0001972481-26-000279
Officer· Chief Medical Officer
Since Mar 2026
6.22K
Shares to sell
$149.0K
Approx. market value
3K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
9/4/2026
3KTotal acquired3K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/4/2026 | Restricted Stock Units Equity Compensation | 3K | — |
| Total | 3K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
3.75K
Market value
$91.2K
9/4/2026
—Completed
Units to sell
1.56K
Market value
$40.9K
8/13/2026
—Completed
Units to sell
887.00
Market value
$16.3K
6/16/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
35.00
Market value
$661.00
9/8/2026
Total
Units
6.22K
Value
$149.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/4/2026 | 3.75K | $91.2K | — | Completed |
8/13/2026 | 1.56K | $40.9K | — | Completed |
6/16/2026 | 887.00 | $16.3K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2026 | 35.00 | $661.00 | Nasdaq | Planned |
| Total | 6.22K | $149.0K | ||